The global Brown-Sequard Syndrome treatment market is poised for significant growth and has a positive outlook as we move towards 2030. The market is expected to witness substantial expansion from 2022, where it was valued at 35.73 USD billion, to 56.52 USD billion by 2030. This growth is attributed to various factors such as increasing prevalence of Brown-Sequard Syndrome, advancements in...